| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |